268
Cannabinoid Receptors 101: Why Do We Have Them?
Visualization of the endocannabinoid signaling system.
https://www.canabomedicalclinic.com/blog/
And with that … Aleafia and Emblem ..
On December 19th, the planned merger was formally announced. Key highlights of that merger include:
• Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;
• Aleafia patients to access Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, along with award-winning customer service and eCommerce platform;
• Regulatory acceleration with Aleafia leveraging Emblem’s Health Canada License to extract and process medical cannabis products and sell them directly to patients;
Aleafia to become among national leaders in production capacity (including committed supply agreements);
• Expansion of Aleafia’s national and global distribution platform;
• Increased scale of the combined company will enhance its capital markets profile and increase trading liquidity; and the combination results in current cash resources of approximately $70 million.
The Leading Canadian Clinic Network: Combining Canabo Medical Clinic and GrowWise Health creates the leading Canadian clinic network with access to 40 national medical clinics and education centres that have served almost 60,000 patients, with increases in patient visits and referrals since October 17, 2018. In addition, Aleafia will be able to leverage Emblem’s extraction, and product innovation to, for the first time, sell high-margin medical cannabis directly to Aleafia’s patient base.
High-Margin, Highly Differentiated Medical Product Portfolio: Aleafia’s patient base will enjoy access to Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, with among industry leading recognized revenue per gram rates. Patients will also access Emblem’s award-winning customer service, schedule home delivery and eCommerce platform.